Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, February 03, 2016
Eleven Biotherapeutics and Albumedix have entered into an agreement that will see Albumedix acquire Eleven’s proprietary Supermin® albumin variant assets.
read more
Wednesday, February 03, 2016
Dr. Reddy's Laboratories has announced that the U.S. Food and Drug Administration (FDA) has approved ZEMBRACE™SymTouch™ (sumatriptan succinate) injection, a drug-device combination product intended for the treatment of acute migraine episodes, with ...
read more
Wednesday, February 03, 2016
Mersana Therapeutics and Takeda Pharmaceutical Company have entered a new strategic partnership granting Takeda rights to Mersana’s lead product candidate, XMT-1522, outside the United States and Canada.
read more
Wednesday, February 03, 2016
Admescope, a preclinical ADME-Tox Contract Research Organisation (CRO), has announced a launch of two new in vitro services. The new service additions, Uptakesubst and Uptakeinhib, are designed to investigate transporter-mediated drug-drug ...
read more
Thursday, February 04, 2016
AmerisourceBergen Corporation and Publix have announced a long-term agreement encompassing the distribution of branded, generic and over-the-counter health and pharmaceutical products.
read more
Thursday, February 04, 2016
AAIPharma Services Corp./Cambridge Major Laboratories, Inc., a provider of custom manufacturing and development services for the pharmaceutical and biotechnology industries, has announced an integrated service offering for solid state chemistry and ...
read more
Thursday, February 04, 2016
Greenphire, a global clinical payment technology company, has announced unprecedented year over year growth as a result of demand for its technology solutions from sponsors, CROs, universities, and hospitals looking to automate their payment ...
read more
Thursday, February 04, 2016
AMRI has announced that Anthony J. Maddaluna, Executive Vice President of Pfizer Inc. and President of Pfizer Global Supply, has been elected to the AMRI Board of Directors, effective as of February 4, 2016.
read more
Thursday, February 04, 2016
3C! Packaging, an independent privately-owned pharmaceutical packaging solutions company specializing in the design and manufacture of custom folding cartons, printed literature, inserts/outserts, labels/foils and unit dose applications, has received...
read more
Monday, February 08, 2016
Nuvo Research has agreed with Horizon Pharma to extend the term of their manufacturing agreement for the production of PENNSAID® 2% for the U.S. market to December 31, 2029, which extends the agreement by an additional seven years.
read more
Monday, February 08, 2016
Patheon has hired Andrew G. Long as senior vice president and global business controller. Long will report to Stuart Grant, chief financial officer for Patheon, and will be based at the company’s headquarters in Durham, N.C.
read more
Tuesday, February 09, 2016
CRYO International, an Air Liquide group subsidiary specializing in temperature-controlled1 logistics solutions, has acquired PDP Couriers, a major player in the customized transport of high value- added products for the pharmaceutical and ...
read more
Tuesday, February 09, 2016
Avista Pharma Solutions has appointed Eric Setzer as Chief Financial Officer (CFO). Mr. Setzer is a finance and operations executive with over twenty years of experience in various roles within growing technology and life science companies.
read more
Tuesday, February 09, 2016
ICON plc, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries has been selected by Genomics England as data management partner for the 100,000 Genomes Project.
read more
Tuesday, February 09, 2016
Cirrus Pharmaceuticals, a Kemwell company, has announced that it is ready to launch its services for manufacturing cGMP materials for early phase clinical trials in its newly constructed state-of-the-art flexi-suite at its Raleigh-Durham, USA, site.
read more